DOI
https://doi.org/10.18849/ve.v7i1.562Abstract
As 2021 draws to a close I suspect few of us could have foreseen the past year. In the early part of the year, as COVID-19 vaccination gathered pace, like many, I was hopeful that we would be seeing coronavirus in the rear-view mirror by the end of the year ― only then to find ourselves in the midst of another wave of cases.
Despite all the headwinds of coronavirus and the impact of working from home, Veterinary Evidence has continued to flourish, publishing more papers this year than last. Published papers have covered an amazing range of different topics, illustrating not just the wide diversity of questions that are being answered, but the depth and breadth of the team of reviewers that give their time to extend veterinary knowledge, supported by a dedicated group of assistant editors and staff at the journal who coordinate activity, ensure standards, and continue to develop the journal.
As a journal, Veterinary Evidence is maturing with two of the main focuses this year being to further develop our internal journal systems ― which has allowed us to apply for membership of COPE (Committee on Publication Ethics) ― and work towards improving the discoverability and accessibility of our published papers. In order to achieve this, the team is working hard to redesign our current website and fulfil the criteria for inclusion in other citation databases beyond CAB Abstracts, such as Medline.
We have been delighted this year to expand our Editorial Board ensuring, as the journal grows, we have the necessary range of skills on the Board to maintain high quality, effective reviews delivered in a timely manner. I would like to take this opportunity to thank all our reviewers and everyone who has served on the Board this year for their tireless efforts on behalf of Veterinary Evidence – without your support the journal could not exist. This year the Board has had three online meetings, more than ever before, which have been essential in helping develop the strategy for Veterinary Evidence over the coming years, expanding the influence and reach of the journal with various strategic initiatives. Other key areas have included developing our policy on standard terminology, looking at the best ways to ensure Knowledge Summaries remain current and working towards making editorial decisions as consistent as possible.
And finally… a huge thank you to everyone who works for and supports Veterinary Evidence, wishing you all a safe and productive 2022.
License
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
Similar Articles
- Peter Cockcroft, Thank You to Our Reviewers , Veterinary Evidence: Vol. 4 No. 1 (2019): The first issue of 2019
- Kit Sturgess, Thank you to our 2020 reviewers , Veterinary Evidence: Vol. 6 No. 1 (2021): The first issue of 2021
- Peter Cockcroft, Thank you to our 2019 reviewers , Veterinary Evidence: Vol. 5 No. 1 (2020): The first issue of 2020
- Peter Cockcroft, Thank You to Our Reviewers , Veterinary Evidence: Vol. 2 No. 4 (2017): The fourth issue of 2017
- Catrina Pennington, Mark Morton, Ben Walton, In canine cranial cruciate ligament rupture is outcome following TPLO improved compared with lateral suture? , Veterinary Evidence: Vol. 4 No. 3 (2019): The third issue of 2019
- Lesca Monica Sofyan, Are glucocorticoids or NSAIDs more effective in reducing idiopathic feline urinary tract disease signs than no treatment or placebo? , Veterinary Evidence: Vol. 6 No. 3 (2021): The third issue of 2021
- Lara Brunori, Does ranitidine administration improve gastrointestinal hypomotility in dogs? , Veterinary Evidence: Vol. 6 No. 1 (2021): The first issue of 2021
- Leanne Barry, In dogs undergoing anaesthesia do pre-anaesthetic gastroprotectants reduce gastro-oesophageal reflux? , Veterinary Evidence: Vol. 5 No. 4 (2020): The fourth issue of 2020
- Lesca Monica Sofyan, In dogs diagnosed with osteoarthritis, is meloxicam superior to carprofen for reducing patient discomfort? , Veterinary Evidence: Vol. 5 No. 3 (2020): The third issue of 2020
- Sara Silva, L. Miguel Carreira, Telmo Nunes, François Saulnier-Troff, A critical appraisal of the literature exploring the surgical treatment of degenerative lumbosacral stenosis in dogs , Veterinary Evidence: Vol. 5 No. 2 (2020): The second issue of 2020
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Kit Sturgess, Thank you to our 2020 reviewers , Veterinary Evidence: Vol. 6 No. 1 (2021): The first issue of 2021